IgniteData's Global Expansion of the Archer Platform
In a landmark announcement,
IgniteData, a leading company in clinical research data technology, unveiled the significant global expansion of its flagship product,
Archer. This innovative platform is transforming healthcare data integration into clinical trials by enhancing how data flows from Electronic Health Records (EHRs) to research databases.
Revolutionizing Clinical Trials
The Archer platform has quickly gained traction among some of the world's most prestigious research institutions. In the past year alone, it has been adopted by numerous top-tier
Academic Medical Centers specializing in areas such as cardiovascular medicine, endocrinology, and oncology. Notably, 70% of the cancer centers designated by the National Cancer Institute (NCI) have either adopted Archer or are in the process of doing so. This includes 8 out of the top 10 centers as ranked by
U.S. News and World Report.
Global Reach
Currently, Archer's deployment spans the United States, Canada, Europe, and Australia, with plans to expand into
Latin America,
Asia, and the
Middle East in the near future. The platform's remarkable growth is evident from its site network, which ballooned by 250% in 2024 and is expected to grow by another 287% in 2025. By the end of 2025, IgniteData anticipates partnering with more than 50 leading research and community networks, facilitating over 1,000 operational sites worldwide.
The Key to Rapid Growth
Dr.
Jose Galvez, the Chief Medical Information Officer at IgniteData and a former Deputy Director of the
FDA, attributes this rapid adoption to the platform's streamlined deployment process. He notes, "The initial install time has decreased from weeks to just days, and the onboarding for new studies is now measured in hours rather than days," making Archer a truly scalable and vendor-agnostic solution for clinical trials.
Site-Centric and Vendor Agnostic
The design of the Archer Platform allows it to act as a connective layer between clinical sites and sponsors. By enabling real-time transfer of source data to sponsor databases, Archer significantly minimizes manual entry errors and promotes full auditability and compliance with regulations. This adaptability ensures that it can seamlessly integrate within various healthcare systems, thereby enhancing operational efficiency on a large scale.
Setting a New Standard in Data Quality
Dr. Galvez emphasizes that Archer's approach is not about overwhelming data transfer. Instead, it focuses on delivering accurate and timely data while maintaining data provenance and compliance, thus enhancing patient safety and data quality.
Unlike many technologies that persist data or create shadow databases, Archer respects data privacy and sovereignty demands while ensuring complete audit tracking. In other words, it routinely meets and exceeds the minimum standards established by regulatory authorities, positioning IgniteData as an industry leader.
Leadership Insights
Zach
Taft, the Chief Executive Officer of IgniteData, stated, "The expansion into the most respected research institutions globally confirms that Archer is more than mere software; it has become the foundational standard for clinical trial data automation." He further highlighted that Archer's superior data compliance not only boosts confidence in data accuracy but also helps accelerate clinical trials while reducing operational risks and costs. Ultimately, the goal is to enhance the quality and safety of therapies delivered to patients worldwide.
About IgniteData
Founded with the mission to automate the integration of high-quality EHR data into clinical trial systems, IgniteData's flagship product, Archer, is now operational in multiple prestigious international research institutions. Its main advantage lies in its ability to securely transfer structured EHR data into sponsor databases, thus improving the sponsor’s efficacy and timelines while simultaneously reducing site burdens. Headquartered in
Delaware, IgniteData is rapidly growing its global footprint, supporting various sponsors and research facilities.
For more information about IgniteData and its innovative services, you can visit
www.ignitedata.com.